LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · IEX Real-Time Price · USD
22.33
+0.52 (2.38%)
At close: Mar 28, 2024, 4:00 PM
22.10
-0.23 (-1.03%)
After-hours: Mar 28, 2024, 7:45 PM EDT

Total Valuation

LENZ has a market cap or net worth of $185.19 million. The enterprise value is -$305,656.

Market Cap 185.19M
Enterprise Value -305,656

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

LENZ has 8.32 million shares outstanding. The number of shares has increased by 3.90% in one year.

Shares Outstanding 8.32M
Shares Change (YoY) +3.90%
Shares Change (QoQ) +0.97%
Owned by Insiders (%) 9.18%
Owned by Institutions (%) 84.43%
Float 2.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.01
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 39.20, with a Debt / Equity ratio of 0.00.

Current Ratio 39.20
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -56.20% and return on invested capital (ROIC) is -73.50%.

Return on Equity (ROE) -56.20%
Return on Assets (ROA) -47.40%
Return on Capital (ROIC) -73.50%
Revenue Per Employee n/a
Profits Per Employee -$20.78M
Employee Count 6
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +30.20% in the last 52 weeks. The beta is 0.20, so LENZ's price volatility has been lower than the market average.

Beta (1Y) 0.20
52-Week Price Change +30.20%
50-Day Moving Average 21.14
200-Day Moving Average 18.27
Relative Strength Index (RSI) 53.03
Average Volume (30 Days) 270,560

Short Selling Information

The latest short interest is 704,044, so 8.46% of the outstanding shares have been sold short.

Short Interest 704,044
Short Previous Month 740,752
Short % of Shares Out 8.46%
Short % of Float 29.55%
Short Ratio (days to cover) 7.93

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -135.19M
Pretax Income -124.65M
Net Income -124.65M
EBITDA -117.96M
EBIT -124.65M
Earnings Per Share (EPS) -$15.33
Full Income Statement

Balance Sheet

The company has $185.86 million in cash and $362,000 in debt, giving a net cash position of $185.50 million or $22.30 per share.

Cash & Cash Equivalents 185.86M
Total Debt 362,000
Net Cash 185.50M
Net Cash Per Share $22.30
Equity / Book Value 183.58M
Book Value Per Share 22.07
Working Capital 183.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$90.01 million and capital expenditures -$8.95 million, giving a free cash flow of -$98.96 million.

Operating Cash Flow -90.01M
Capital Expenditures -8.95M
Free Cash Flow -98.96M
FCF Per Share -$12.15
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LENZ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.90%
Shareholder Yield -3.90%
Earnings Yield -67.31%
FCF Yield -53.44%

Analyst Forecast

The average price target for LENZ is $28.00, which is 25.39% higher than the current price. The consensus rating is "Buy".

Price Target $28.00
Price Target Difference 25.39%
Analyst Consensus Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 1:7.

Last Split Date Mar 22, 2024
Split Type Reverse
Split Ratio 1:7

Scores

Altman Z-Score n/a
Piotroski F-Score 3